Dengue

Filter by:

Dengue

Setback in Dengue vaccine program highlights the need for effective and free Dengue antivirals

November 30, 2017 by fhu in Dengue

Today it was announced that the use of the only approved Dengue vaccine, Dengvaxia, is to be strictly limited due to evidence it can worsen the disease in people who

Antivirals for the
Developing World

We develop revolutionary new antiviral agents based on an existing portfolio of highly active pharmaceutical compounds that was granted to our organisation by our sponsor First Health Pharmaceuticals.

We do not perform basic research which (although of great importance for scientific progress in the long run) can take decades and require enormous investments before potential new pharmaceuticals are discovered.

We already possess antiviral agents with proven activity and with your help we will bring them to the patients as soon as possible. We specifically target viruses that offer limited economic perspective to the pharmaceutical industry but are of great importance to the Developing World.